Ask anything about research
Search papers, query evidence, get expert commentary — all in one place
ACC 2026 Late-Breaking Trials
Live trial results, expert commentary, and discussion with 10+ trial authors
Hot Research Today
Papers from every journal, all in one place
Advanced Molecular, Metabolic, and Imaging Approaches to Characterizing Right Ventricular Failure: A Scientific Statement From the American Heart Association
✨ Key Finding: Right ventricular maladaptive remodeling and pulmonary arterial uncoupling drive right heart failure, making the right ventricle a central therapeutic target in pulmonary hypertension.
2026 Dietary Guidance to Improve Cardiovascular Health: A Scientific Statement From the American Heart Association
The scientific statement provides guidance on heart-healthy dietary patterns for reducing cardiovascular disease risk.
“参考文献： https://t.co/UFBkLaUJcr”
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks
✨ Key Takeaway: Abbreviated or de-escalated dual antiplatelet therapy reduces bleeding and improves net clinical outcomes in the 20-40% of acute coronary syndrome patients classified as high bleeding risk.
Optimal Ablation Strategies for Persistent Atrial Fibrillation With Heart Failure: Three-Year Follow-Up of a Prospective Multicenter Randomized Trial
✨ Key Finding: Extensive electro-anatomic-guided ablation achieved the lowest 36-month rate of cardiovascular events (17.0%) and highest sinus rhythm maintenance (62.0%) in patients with persistent AF and HF.
Perioperative Cardiovascular Medication Management for Noncardiac Surgery
Clinical guidelines summarize CV medication management in noncardiac surgery, highlighting new recommendations.
Sex Differences in Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants for Atrial Fibrillation: An ASPERA‐R Inverse Probability Weighted Analysis
✨ Key Finding: Women with breakthrough ischemic stroke on oral anticoagulants for atrial fibrillation had lower rates of return to baseline neurologic function than men (35.2% vs 42.7%; aRR 0.82).
Implementing the GWTG‐CAD Program in Mexico: Feasibility, Challenges and Lessons Learned for Acute and Secondary Prevention and Management
✨ Key Finding: Implementation of the GWTG-CAD program in Mexico increased the proportion of patients receiving an ECG within 10 minutes of arrival from 61% to 93% over 18 months.
Pre-heart failure in early chronic kidney disease: clinical epidemiology and treatment
✨ Key Finding: Early chronic kidney disease is strongly associated with subclinical pre-heart failure, which can be mitigated by cardiorenal therapies including SGLT2 inhibitors and finerenone.
Ten Years Real-World Experience With Sacubitril/Valsartan in Patients With Heart Failure With Reduced Ejection Fraction
This review shows the effectiveness and safety of sacubitril/valsartan in heart failure patients, highlighting implementation gaps.
Patient Care Pathways and Outcomes Following Newly Diagnosed Atrial Fibrillation
✨ Key Finding: Electrophysiologist visits for incident atrial fibrillation were associated with increased oral anticoagulation rates and significantly lower stroke risk (HR 0.63) in patients aged ≥80 years.